drugset / Trial / NCT00040495

Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage

NCT00040495

Phase 3 Completed 149 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
Prevention

Summary

The purpose of this study is to evaluate the efficacy and safety of intravenous pantoprazole in the prevention of rebleeding in patients with bleeding peptic ulcer disease after successful endoscopic hemostatic therapy.

Timeline

Start
2001-04
Primary completion
2003-01
Completion
2003-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pantoprazole Other / unclassified Intravenous

Indications